Professor Chris Day
Professor Alastair Burt
| Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment | 2019 |
|
Dr Dave Houghton
Dr Kate Hallsworth
Dr Sophie Cassidy
Christian Thoma
Dr Leah Avery
et al. | The degree of hepatic steatosis associates with impaired cardiac and autonomic function | 2019 |
|
Dr Steven Masson
Professor Ann Daly
Professor Heather Cordell
Professor Chris Day
| Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosis | 2018 |
|
Professor Quentin Anstee
Professor Chris Day
Professor Arun Sanyal
| Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030 | 2018 |
|
Dr Dave Houghton
Dr Timothy Hardy
Dr Christopher Stewart
Linda Errington
Professor Chris Day
et al. | Systematic review assessing the effectiveness of dietary intervention on gut microbiota in adults with type 2 diabetes | 2018 |
|
Dr Stuart McPherson
Dr Nina Wilson
Dr Dina Tiniakos
Dr Jennifer Wilkinson
Professor Alastair Burt
et al. | A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis | 2017 |
|
Dr Stuart McPherson
Dr Timothy Hardy
Dr Dina Tiniakos
Professor Alastair Burt
Professor Chris Day
et al. | Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis | 2017 |
|
Dr Sally Coulthard
Professor Chris Day
Professor Ann Daly
| Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study | 2017 |
|
Dr Dave Houghton
Dr Sophie Cassidy
Dr Christian Thoma
Dr Kate Hallsworth
Dr Leah Avery
et al. | Autonomic function is impaired across the spectrum of NAFLD | 2017 |
|
Dr Mikolaj Ogrodnik
Dr Satomi Miwa
Dr Dina Tiniakos
Dr Caroline Wilson
Professor Chris Day
et al. | Cellular senescence drives age-dependent hepatic steatosis | 2017 |
|
